about
Towards tumor immunodiagnosticsTumour progression and metastasisThe Dichotomy of Tumor Exosomes (TEX) in Cancer Immunity: Is It All in the ConTEXt?The role of regulatory T cells in cancer immunologyMonitoring of the Immune Dysfunction in Cancer PatientsMicroenvironmental regulation of tumor progression and metastasisMelanoma NOS1 expression promotes dysfunctional IFN signalingDendritic cells decreased the concomitant expanded Tregs and Tregs related IL-35 in cytokine-induced killer cells and increased their cytotoxicity against leukemia cells.Dissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphoma.Decreased intratumoral Foxp3 Tregs and increased dendritic cell density by neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancerTGFβ in T cell biology and tumor immunity: Angel or devil?Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment.Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology.Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets.Decreased FOXP3+ and GARP+ Tregs to neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer.TH9 cells in anti-tumor immunity.Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy.Spatial distribution of FoxP3+ and CD8+ tumour infiltrating T cells reflects their functional activity.Prostate cancer vaccines.Natural and induced T regulatory cells in cancer.Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance.Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?Regulatory T cells and the immune aging process: a mini-reviewInduced regulatory T cells in inhibitory microenvironments created by cancer.Designing effective vaccines for colorectal cancer.Clinical Impact of Regulatory T cells (Treg) in Cancer and HIV.The role of regulatory T cells and microglia in glioblastoma-associated immunosuppression.Increasing glioma-associated monocytes leads to increased intratumoral and systemic myeloid-derived suppressor cells in a murine model.Ontogeny of Tumor-associated CD4+CD25+Foxp3+ T-regulatory Cells.Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells.TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment.Therapy model for advanced intracerebral B16 mouse melanoma using radiation therapy combined with immunotherapy.CD4+FOXP3+ T regulatory cells decrease and CD3+CD8+ T cells recruitment in TILs from melanoma metastases after electrochemotherapy.T-cell subsets in autologous and allogeneic peripheral blood stem cell concentrates.Human papilloma virus status of penile squamous cell carcinoma is associated with differences in tumour-infiltrating T lymphocytes.Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence.Generation and immunosuppressive functions of p53-induced human adaptive regulatory T cells.Efferocytosis creates a tumor microenvironment supportive of tumor survival and metastasis.The Dual Role of Treg in Cancer.Targeting complement-mediated immunoregulation for cancer immunotherapy.
P2860
Q26738691-A07A387B-8FE8-4A33-B2CD-BCEF790D0532Q26766468-5BEBA190-41C3-4183-93BE-3863AEBCA180Q26773307-D49AF1E4-6126-4BD2-8B93-F14AFF003AFDQ27006663-1E185FF6-7017-44FF-A474-834CB2E39981Q28072712-95A519BF-27BE-4AFE-B4C4-16869BAEC9DFQ29615504-1FD46F16-AC57-4F6D-B9C7-920627AB5D36Q30413226-ED114FA5-97B3-4D6F-BF7D-1638290F5F77Q31157715-B08E2FD7-9EE4-439A-BEDD-0480EF838415Q34041661-1CF7882B-6399-4B8C-84EE-C6B91BFE7858Q34121330-B7F09125-B58D-4EA2-AEAA-777C0C79C8D1Q34276027-9E810182-CDFE-4D29-8359-CF238232D6D9Q35507024-C1D54F07-2C29-4D8B-A793-C8DD6C4F3CFBQ35893711-C87CBCF3-5D2F-4CCD-9097-AEC40954F3AEQ36542190-1EC5C044-2D75-4987-A0F5-86961EC64C02Q37020109-BC14CDF9-79A6-496D-A0B2-D127C906BD54Q37575177-B5B7B9A1-5E35-49D0-B8F6-79AF7F67BA52Q37635491-76A08281-8ABD-4516-8BB6-3C3522027514Q37645030-53D43152-5B20-4825-93F9-5C9B0BB16D9FQ38089935-72FA6888-B5B4-428B-AA46-64653DB9F24BQ38123165-68B7C212-D564-4AB8-B643-88679D2A8B88Q38154886-56C66294-A63A-479E-859A-CBC21E5A21F9Q38161416-F38DC0E6-291F-4C42-817B-38102790329BQ38168042-503388F4-1D22-43B7-8B31-8977A1C8D599Q38220701-1C22B858-6856-430A-87CD-4B0768647A22Q38260051-4CB04221-6026-4DE0-B805-237707479E78Q38266807-763203A7-2E7F-4C4C-B79C-49DF61A8F004Q38540262-1A418D6C-584F-402A-A62E-86F989312BC4Q38925761-4F12ACF4-DD01-4AB5-A7FC-EC8CF30A7306Q38985262-689D4AAF-501E-4601-B417-A0D2696A4B33Q39002543-70F1C605-6FA4-4734-9B6C-FFAC508EA03AQ39071510-DFC593C1-AD76-4251-A637-B2A3729AD3B0Q39161026-26B4578D-F3EF-48E0-A80C-E955D064E742Q39541849-EA36F0D4-8048-4CDF-B593-72F4893A874CQ40871937-79A19A36-0923-49A0-91ED-19374AEB7175Q41579102-106F0CF9-5C5E-4B07-B6D3-FB1140E69FD2Q42084378-13E27F14-1E1B-43B0-862E-D13EBFC4D7BBQ42969880-E01EE0F4-05AA-4B8D-ACA8-E68DFEB9F911Q47153678-E6D5138D-6C9E-425B-837C-1E8EEBEDB3E4Q47755372-E7395280-706C-48F3-80B5-59FE7DC96922Q49898514-E1D1AC35-47F9-49E5-8436-A0DB4BC42DA7
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Induced and natural regulatory T cells in human cancer.
@en
type
label
Induced and natural regulatory T cells in human cancer.
@en
prefLabel
Induced and natural regulatory T cells in human cancer.
@en
P2093
P2860
P1476
Induced and natural regulatory T cells in human cancer.
@en
P2093
Bastian Schilling
Patrick Schuler
Theresa L Whiteside
P2860
P304
P356
10.1517/14712598.2012.707184
P407
P577
2012-07-31T00:00:00Z